Next Article in Journal
Evaluation of Antioxidant, Antidiabetic and Anticholinesterase Activities of Smallanthus sonchifolius Landraces and Correlation with Their Phytochemical Profiles
Next Article in Special Issue
Curcumol Inhibits Growth and Induces Apoptosis of Colorectal Cancer LoVo Cell Line via IGF-1R and p38 MAPK Pathway
Previous Article in Journal
Unveiling the Mode of Action of Two Antibacterial Tanshinone Derivatives
Previous Article in Special Issue
The Effect of Growth Hormone Administration on the Regulation of Mitochondrial Apoptosis in-Vivo
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 16
Issue 8
10.3390/ijms160817682
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

MiR-30b Is Involved in the Homocysteine-Induced Apoptosis in Human Coronary Artery Endothelial Cells by Regulating the Expression of Caspase 3

by
Feng Li
1,†,
Qi Chen
1,†,
Xiaowei Song
1,
Lei Zhou
2 and
Jianliang Zhang
1,*
1
Department of Cardiology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China
2
Department of Cadre Recuperation, Navy Medical Service Sanatorium, Hangzhou 310002, China
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Int. J. Mol. Sci. 2015, 16(8), 17682-17695; https://doi.org/10.3390/ijms160817682
Submission received: 3 April 2015 / Revised: 20 July 2015 / Accepted: 24 July 2015 / Published: 31 July 2015
(This article belongs to the Collection Programmed Cell Death and Apoptosis)
Browse Figures
Versions Notes

Abstract

:
Homocysteine (Hcy) is an independent risk factor for a variety of cardiovascular diseases, such as coronary heart disease, hypertension, stroke, etc. There is a close relationship between the vascular endothelial cell apoptosis and these diseases. Recent studies have shown homocysteine can induce apoptosis in endothelial cells, which may be an important mechanism for the development of theses cardiovascular diseases. Although there are several reports about how the Hcy induces apoptosis in endothelial cells, the exact mechanism is not fully understood. MicroRNAs are small, non-coding RNA. Previous studies have shown that there is a close relationship between several microRNAs and cell apoptosis. However, there are no studies about the role of microRNAs in Hcy-induced apoptosis in endothelial cells so far. In this study, we constructed the model of homocysteine-induced apoptosis in human coronary artery endothelial cells (HCAECs) and found miR-30b was significantly down-regulated by 1 mmol/L Hcy. In addition, overexpression of miR-30b can improve the Hcy-induced apoptosis in HCAECs by downregulating caspase-3 expression. Therefore, miR-30b may play an important role in Hcy-induced apoptosis in endothelial cells.

1. Introduction

Homocysteine (Hcy) is an intermediate metabolite in the metabolic pathway of cysteine and methionine. Previous studies have revealed that high levels of serum Hcy are independent risk factors of a variety of cardiovascular diseases, such as coronary heart disease, hypertension and stroke [1,2,3,4]. As we all know, vascular endothelial cells have an important role in normal physiological processes including the secretion of a variety of biologically active substances, including chemokines and cell adhesion factor, mediating immune inflammatory reaction, adjusting coagulation and fibrinolysis system, regulating vascular relaxation and contraction, promoting angiogenesis, etc. There is a close relationship between dysfunction of endothelial cells and cardiovascular diseases [5]. Hcy can induce apoptosis in endothelial cells [6,7,8], and the apoptosis induced by Hcy in endothelial cells is regarded as the one of the mechanisms leading to these cardiovascular diseases. Previous studies have found that Hcy induces endothelial cells apoptosis mainly through the death receptor pathway, the mitochondrial apoptotic pathway and the endoplasmic reticulum stress pathway, but the exact mechanism for how Hcy induces apoptosis in endothelial cells is not fully understood.
MicroRNAs are a class of small, non-coding RNA, which can affect the expression of target genes in the post-transcriptional level, change intracellular protein groups, and regulate apoptosis, proliferation, differentiation, and other physiological functions [9]. The recent accumulation of research results indicates that microRNAs play a significant role in regulating endothelial cell apoptosis. As we all know, Dicer is a key enzyme involved in the maturation of microRNAs. Previous study has found that overexpression of Dicer in human umbilical vein endothelial cells (HUVECs) markedly decreases apoptosis upon serum withdrawal [10]. In addition to Dicer, several individual microRNAs have been identified to have a key role in regulating endothelial cell apoptosis. Liu and colleagues have demonstrated that silencing of miR-155 leads to a reduction of apoptosis and reactive oxygen species production in human brain microvessel endothelial cells [11]. Qin et al. reported that downregulation of miR-221/222 in HUVECs by ox-LDL resulted in endothelial cell apoptosis, whereas overexpression of miR-221/222 in HUVECs markedly decreased apoptosis induced by ox-LDL via Ets-1/p21 pathway [12]. Furthermore, several other microRNAs are also shown to be important in regulating endothelial cell apoptosis, including miR-19a, miR-26a, miR-495, miR-US25-1, miR-223, let-7, miR-126, miR-21, miR-590-5p, miR-513a-5p, miR-23a, miR-365, etc. [13,14,15,16,17,18,19,20,21,22,23,24]. Overall, these studies indicate that microRNAs are crucial for the regulation of endothelial cell apoptosis.
Previous studies have shown that microRNAs are involved in Hcy-induced cardiovascular dysfunctions, such as cardiac remodeling and stroke [25,26]. However, there are no studies about the role of microRNAs in Hcy-induced apoptosis in endothelial cells so far. To further understand the molecular mechanism of Hcy-induced apoptosis in HCAECs, providing new drug targets and therapeutic orientation of intervention Hcy-induced endothelial dysfunction, the present study determined the role of miR-30b in Hcy induced apoptosis in the vascular endothelial cells.

2. Results

2.1. Hcy Induce Apoptosis in HCAECs by Upregulating the Expression of Caspase-3 in a Dose-Dependent Manner

The HCAECs were treated with the Hcy of 0.1, 0.3, 0.6, 1.0, 1.3, 1.6 and 2.0 mmol/L concentration for 24 h. To observe the influence of Hcy on the HCAECs, the expression of caspase-3 mRNA was detected by real-time qPCR (Figure 1A), the expression of caspase-3 protein was detected by Western Blot (Figure 1B), the apoptosis rate was detected by flow cytometry with AnnexinV/PI staining (Figure 2 and Table 1). It was shown in Figure 1A that 1 mmol/L and above Hcy can significantly increase the expression of the caspase-3 mRNA (1.40-fold for 1 mmol/L Hcy, 1.48-fold for 1.3 mmol/L Hcy, 1.58-fold for 1.6 mmol/L Hcy, 1.72-fold for 2 mmol/L Hcy vs. control group, p < 0.05, respectively), while 0.1, 0.3 and 0.6 mmol/L Hcy did not significantly increase, compared with the control group. The Western Blot results were shown in Figure 1B that Hcy can increase the expression of the caspase-3 protein in a dose-dependent manner. To confirm the apoptosis of Hcy-induced in HCAECs, the apoptosis rate was detected and the results were shown in Figure 2 and Table 1. Hcy concentrations of 0.3 mmol/L and higher can significantly increase apoptosis in HCAECs (9.88% ± 0.86% for 0.3 mmol/L Hcy, 15.35% + 0.41% for 0.6 mmol/L Hcy, 16.28% ± 0.44% for 1 mmol/L Hcy, 19.72% ± 0.46% for 1.3 mmol/L Hcy, 32.9% ± 0.54% for 1.6 mmol/L, 48.76% ± 3.08% for 2 mmol/L Hcy vs. 5.92% ± 0.34% for control, p < 0.05).
Ijms 16 17682 g001 1024
Figure 1. (A) The impact on expression of caspase 3 mRNA by different concentrations Hcy on HCAECs. The time of treatment was 24 h. Compared with the control group, * p < 0.05, ** p < 0.01, n = 3 in each group; and (B) The impact on expression of caspase 3 protein by different concentrations Hcy on HCAECs. The time of treatment was 24 h. From left to right is the control group, Hcy 0.1 mmol/L group, Hcy 0.3 mmol/L group, Hcy 0.6 mmol/L group, Hcy 1.0 mmol/L group, Hcy 1.3 mmol/L group, Hcy 1.6 mmol/L group, Hcy 2.0 mmol/L group.
Figure 1. (A) The impact on expression of caspase 3 mRNA by different concentrations Hcy on HCAECs. The time of treatment was 24 h. Compared with the control group, * p < 0.05, ** p < 0.01, n = 3 in each group; and (B) The impact on expression of caspase 3 protein by different concentrations Hcy on HCAECs. The time of treatment was 24 h. From left to right is the control group, Hcy 0.1 mmol/L group, Hcy 0.3 mmol/L group, Hcy 0.6 mmol/L group, Hcy 1.0 mmol/L group, Hcy 1.3 mmol/L group, Hcy 1.6 mmol/L group, Hcy 2.0 mmol/L group.
Ijms 16 17682 g001
Ijms 16 17682 g002 1024
Figure 2. The apoptosis rate of different concentrations Hcy induced on HCAECs by flow cytometry in each group. The time of treatment was 24 h. (A–H), respectively, on behalf of the control group, Hcy 0.1 mmol/L group, Hcy 0.3 mmol/L group, Hcy 0.6 mmol/L group, Hcy 1.0 mmol/L group, Hcy 1.3 mmol/L group, Hcy 1.6 mmol/L group, Hcy 2.0 mmol/L group.
Figure 2. The apoptosis rate of different concentrations Hcy induced on HCAECs by flow cytometry in each group. The time of treatment was 24 h. (A–H), respectively, on behalf of the control group, Hcy 0.1 mmol/L group, Hcy 0.3 mmol/L group, Hcy 0.6 mmol/L group, Hcy 1.0 mmol/L group, Hcy 1.3 mmol/L group, Hcy 1.6 mmol/L group, Hcy 2.0 mmol/L group.
Ijms 16 17682 g002
Table
Table 1. Apoptosis rate of different concentrations of Hcy-induced in HCAECs.
Table 1. Apoptosis rate of different concentrations of Hcy-induced in HCAECs.
Group (n = 3)Apoptosis Rate % (LR + UR)
control5.92 ± 0.34
Hcy 0.1 mmol/L6.5 ± 0.32
Hcy 0.3 mmol/L9.88 ± 0.86 *
Hcy 0.6 mmol/L15.35 + 0.41 **
Hcy 1.0 mmol/L16.28 ± 0.44 **
Hcy 1.3 mmol/L19.72 ± 0.46 **
Hcy 1.6 mmol/L32.9 ± 0.54 **
Hcy 2.0 mmol/L48.76 ± 3.08 **
Compare to the control group, * p < 0.05, ** p < 0.01 (n = 3 in each group); Abbreviations of the samples means: LR, Low right quadrants in the apoptosis figure of the flow cytometry, UR, Up right quadrants in the apoptosis figure of the flow cytometry.

2.2. MiR-30b Is Downregulated during Hcy-Induced Apoptosis in HCAECs

In the first part of this study, we found that 1 mmol/L Hcy can significantly increase the expression of caspase-3 mRNA by real-time qPCR (Figure 1A). So, the HCAECs were treated with 1 mmol/L Hcy for 24 h and several microRNAs which expressed in endothelial cells were detected by real-time qPCR (Figure 3). MiR-30b is downregulated 0.49-fold during Hcy-induced apoptosis in HCAECs, compared with control group (p < 0.05).
Ijms 16 17682 g003 1024
Figure 3. The expression of microRNAs in apoptosis Hcy-induced in HCAECs. The time of treatment was 24 h. Compared with the control group, * p < 0.05, n = 3 in each group.
Figure 3. The expression of microRNAs in apoptosis Hcy-induced in HCAECs. The time of treatment was 24 h. Compared with the control group, * p < 0.05, n = 3 in each group.
Ijms 16 17682 g003

2.3. Overexpression of miR-30b Inhibits the Apoptosis Induced by Hcy in HCAECs

To investigate the role of miR-30b in Hcy-induces apoptosis in the HCAECs, we upregulated the expression of miR-30b by transfecting with miR-30b mimics in HCAECs. When 100 ng miR-30b mimics were transfected into HCAECs, the level of miR-30b increased up to 1.5-fold compared with control group and miR-30b negative group, p < 0.05 (Figure 4). The HCAECs were treated with 1 mmol/L Hcy for 24 h after confirming the success and efficiency of the miR-30b transfection. It was shown in Figure 5 and Table 2 that overexpression of miR-30b in HCAECs significantly improved the Hcy-induced apoptosis (10.59% ± 0.6% for Hcy miR-30b overexpressed group, 15.83% ± 0.51% for Hcy negative group, 4.77% ± 1.23% for control group, p < 0.05). The influence of miR-30b overexpression on caspase-3 was also detected by real-time qPCR and Western blot. It was shown that the upregulation of caspase-3 by Hcy was significantly suppressed by miR-30b mimics both in mRNA level (Figure 6) and protein level (Figure 7). The increased expression of the cleaved caspase-3 induced by Hcy, which represented the activity of the caspase-3, was also significantly reduced by miR-30b mimics (Figure 7). The results of the Figure 7 are listed in Supplementary Tables S1 and S2. These data suggest that miR-30b plays an important role in the regulation of endothelial cell apoptosis induced by Hcy in vitro.
Ijms 16 17682 g004 1024
Figure 4. The expression of miR-30b upregulated after transfection of miR-30b mimic in HCAECs. The time of transfection was 24 h. Compared with the control group, the negative control group, p < 0.05 (n = 6 in each group).
Figure 4. The expression of miR-30b upregulated after transfection of miR-30b mimic in HCAECs. The time of transfection was 24 h. Compared with the control group, the negative control group, p < 0.05 (n = 6 in each group).
Ijms 16 17682 g004
Ijms 16 17682 g005 1024
Figure 5. AnnexinV/PI flow cytometry apoptosis chart, on behalf of the control group (A); Hcy negative control group (B); and Hcy miR-30b overexpressed group (C). The concentration of Hcy was 1 mmol/L, both the time of transfection and treatment of Hcy were 24 h (n = 4 in each group).
Figure 5. AnnexinV/PI flow cytometry apoptosis chart, on behalf of the control group (A); Hcy negative control group (B); and Hcy miR-30b overexpressed group (C). The concentration of Hcy was 1 mmol/L, both the time of transfection and treatment of Hcy were 24 h (n = 4 in each group).
Ijms 16 17682 g005
Table
Table 2. Apoptosis rate of Hcy-induced in HCAECs.
Table 2. Apoptosis rate of Hcy-induced in HCAECs.
Group (n = 4)Apoptosis Rate % (LR + UR)
Control group4.77 ± 1.23
Hcy negative control group15.83 ± 0.51 *
Hcy miR-30b overexpressed group10.59 ± 0.6 *,#
Compared with the control group, * p < 0.05; Compared with the negative control group, #, p < 0.05 (n = 4 in each group); Abbreviations of the samples means: LR, Low right quadrants in the apoptosis figure of the flow cytometry; UR, Up right quadrants in the apoptosis figure of the flow cytometry.
Ijms 16 17682 g006 1024
Figure 6. The expression of miR-30b and caspase-3 mRNA after overexpression of miR-30b in Hcy-induced HCAECs. The concentration of Hcy was 1 mmol/L, both the time of transfection and treatment of Hcy were 24 h. (A) shows the transfection of miR-30b mimic significantly up-regulated the expression of miR-30b which Hcy reduced; and (B) shows the overexpression of miR-30b down-regulated the expression of caspase-3 mRNA which Hcy induced. Compared with the control group, compared with the Hcy + miR-30b negative group, p < 0.05, n = 6 in each group.
Figure 6. The expression of miR-30b and caspase-3 mRNA after overexpression of miR-30b in Hcy-induced HCAECs. The concentration of Hcy was 1 mmol/L, both the time of transfection and treatment of Hcy were 24 h. (A) shows the transfection of miR-30b mimic significantly up-regulated the expression of miR-30b which Hcy reduced; and (B) shows the overexpression of miR-30b down-regulated the expression of caspase-3 mRNA which Hcy induced. Compared with the control group, compared with the Hcy + miR-30b negative group, p < 0.05, n = 6 in each group.
Ijms 16 17682 g006
Ijms 16 17682 g007 1024
Figure 7. The expression of procaspase-3 and cleaved caspase-3 protein after overexpression of miR-30b in Hcy-induced HCAECs, the concentration of Hcy was 1 mmol/L, both the time of transfection and treatment of Hcy were 24 h.
Figure 7. The expression of procaspase-3 and cleaved caspase-3 protein after overexpression of miR-30b in Hcy-induced HCAECs, the concentration of Hcy was 1 mmol/L, both the time of transfection and treatment of Hcy were 24 h.
Ijms 16 17682 g007

3. Discussion

Since McCully found a close relationship between the levels of serum Hcy and atherosclerosis by autopsy in 1969 [27], the vascular complications by Hcy-induction raises concern. There is a close relationship between Hcy and cardiovascular diseases, and the endothelial cells’ apoptosis induced by Hcy is regarded as one of the most important mechanisms.
MicroRNAs are a class of small, non-coding RNA discovered in recent years. Accumulating evidence suggests important roles of microRNAs in the regulation of cell apoptosis. MiR-495 regulates proliferation and apoptosis in HUVECs by targeting the chemokine CCL2 [15]. Platelet-secreted microRNA-223 promotes endothelial cell apoptosis induced by advanced glycation end products via targeting the insulin-like growth factor 1 receptor [17]. Let-7g can inhibit oxidation of LDL-induced apoptosis in endothelial cell by regulating the expression of target gene caspase-3 [18]. However, there is no study reported about the role of microRNAs in Hcy-induced endothelial cell apoptosis so far.
To observe the role of microRNA in Hcy-induced apoptosis in endothelial cells, the Hcy-induced apoptosis model was constructed in HCAECs. For now, the majority of the previous apoptosis models were constructed on HUVECs, several were constructed on rat aortic endothelial cells and microvascular endothelial cells. Human vascular complications Hcy-induced mainly occurred in artery, so the HCAECs apoptosis model used in this study was more in accordance with the actual physiological situation of the body, compared with common HUVEC apoptosis models. Caspase-3 is a member of the cysteine-aspartic acid protease (caspase) family. It is the most important nucleic acid-cleaving enzyme of the apoptosis pathways, which plays an irreplaceable role in the cell apoptosis. So, the expression of caspase-3 was used to evaluate Hcy-induced apoptosis in HCAECs in this study. Previous studies have found that 500 µmol/L–1 mmol/L Hcy can significantly increase the apoptosis in HUVECs [7,8]. In our study, the expression of caspase-3 mRNA was significantly upregulated by 1 mmol/L Hcy, and the results were consistent with the previous date. Kerkeni M reported that the HUVECs can be treated with 10 mmol/L Hcy [28], but in our pre-experiment, almost all the HCAECs were not viable when treated with 3 mmol/L Hcy. These findings suggest that HCAECs have similar sensitivity but less tolerance for Hcy, compared with HUVECs.
In this study, several microRNAs which were in abundance in endothelial cells were detected by real-time qPCR. The miR-30b was significantly downregulated by 1 mmol/L Hcy. Previous studies have shown that miR-30b is involved in cell apoptosis by regulating the expression of caspase-3. Li constructed the ischemia-reperfusion (I/R) injury model in H2C9 rat myocardial cells and found the overexpression of miR-30b down-regulated the expression of caspase-3 and improve I/R injury in H2C9 cells [29]. Similarly, Song et al., demonstrated that miR-30b levels were down-regulated by I/R injury in rat myocardial cells. Furthermore, overexpression of miR-30b inhibited myocardial cells apoptosis and exhibited a dramatic reduction of caspase-3 expression [30]. Zhu reported that miR-30b was significantly downregulated in human gastric cancer tissues, and overexpression of miR-30b in SGC-7901 or HGC-27 tumor cells can significantly promote cell apoptosis compared with the control group [31]. Liao found the expression level of miR-30b is low in colon cancer tissues, and the lower the level of miR-30b, the worse the differentiation and prognosis of colon cancer; overexpression of miR-30b can inhibit the proliferation and promote apoptosis of cancer cells apoptosis [32]. These studies indicate that miR-30b has an important role in regulating cell apoptosis and links with the caspase-3 expression. Because caspase-3 was the main indicator of apoptosis detected in this study, we chose miR-30b for further research. In addition to miR-30b, miR-18a was also significantly downregulated by 1 mmol/L Hcy in our study, and several researches had reported the important role of miR-18a in regulating cell apoptosis [33,34,35]. We believe that there should be more microRNAs involved in the process of the apoptosis Hcy-induced on HCAECs. Unfortunately, in this study, we only discussed the function and mechanism of miR-30b.
To further investigate the role of miR-30b in Hcy-induces apoptosis in HCAECs, miR-30b mimics were transfected into the HCAECs. Compared with the control group, the expression of miR-30b which was detected by real-time qPCR was significantly upregulated. Overexpression of miR-30b can inhibit the Hcy-induced apoptosis by downregulating the expression of caspase-3. Our study indicated that miR-30b was involved in the Hcy-induced apoptosis in HCAECs by regulating the expression of caspase-3. Interestingly, previous study has reported that Hcy-thiolactone which is a metabolite of Hcy, but not Hcy, induces apoptotic death in HUVECs in a caspase-3 independent way [36]. Furthermore, a recent article indicates that each of Hcy metabolites including Hcy-thiolactone and N-Hcy-protein induces a specific pattern of gene expression [37]. Are the changes of gene expression at high Hcy concentrations in our study are due to the accumulation of Hcy-thiolactone and/or N-Hcy-protein? Unfortunately, we did not carry out further research and analysis on this issue. Perhaps, in the future course of experiments, we will confirm this hypothesis.

4. Experimental Section

4.1. Reagents and Cell Cultures

HCAECs were kindly provided by Dr. Q.Jing (The Changhai Hospital, Shanghai, China) and cultured in ECM endothelial growth medium (ScienCell, San Diego, CA, USA) supplemented with 5% FBS and 100 U/mL penicillin/streptomycin at 37 °C under 5% CO2. d,l-Hcy (Sigma, Saint Louis, MO, USA) was dissolved in the ECM Medium. After the HCAECs grew to about 80% confluence, the cells were treated with Hcy of various concentration (0.1 mmol/L, 0.3 mmol/L, 0.6 mmol/L, 1.0 mmol/L, 1.3 mmol/L, 1.6 mmol/L, 2.0 mmol/L) for 24 h. Post Hcy incubation, the cells were collected for the apoptosis rate detection, mRNA expression analysis and Western blotting analysis.

4.2. Apoptosis Assays

The apoptosis rate was determined by flow cytometry with AnnexinV/PI staining (BD Biosciences, San Jose, CA, USA). Briefly, the HCAECs of each group were collected in 1.5 mL eppendorf, and washed by binding buffer. Each eppendorf contains about 1–5 × 105 cells. The cells were resuspended in 100 µL and incubated with annexin V-FITC for 15 min in the dark at room temperature. Then, each eppendorf cells washed by binding buffer again and resuspended in 200 µL. After each group of cells were incubated with PI for 1 min, the apoptosis rates of Hcy-induced in HCAECs were detected by flow cytometry.

4.3. RNA Isolation, Reverse Transcription, Real-Time qPCR

Each group cells were lyzed by Trizol (Invitrogen, Carlsbad, CA, USA) and total cellular RNA were collected. RNA electrophoresis and densitometry were used to identify RNA quality. For quantitative analysis of caspase-3 mRNA expression and microRNAs expression, the special primers of caspases-3 and microRNAs (BioSune, Shanghai, China) were used in the follow-up experiments. Primer sequences are shown in the Table 3 and Table 4. The cellular RNA of each group (100–500 ng) was reversed into cDNA in reverse transcription reaction. The total reaction system is 10 µL and the reaction conditions were 16 °C for 30 min, 42 °C for 90 min, 72 °C for 5 min. Then, the reverse transcription products were amplified for real-time qPCR reaction after which were diluted 10 folds with PCR water. The conditions of real-time qPCR were 94 °C for 30 s, 60 °C for 30 s, 72 °C for 30 s, with 40 cycles in total. Relative quantification was determined using the ΔΔCt method, U6 was used as reference gene.
Table
Table 3. Primer for reverse transcription.
Table 3. Primer for reverse transcription.
Primer NamePrimer Sequence
hsa-miR-10a-5p RT primer5′-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACCACAAATT-3′
hsa-miR-28-5P RT primer5′-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACCTCAAT-3′
hsa-miR-22-5p RT primer5′-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACTAAAGC-3′
hsa-miR-140-5p RT primer5′-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACCTACCA-3′
hsa-miR-18a-5p RT primer5′-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACCTATCT-3′
hsa-miR-128 RT primer5′-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACAAAGAG-3′
hsa-miR-124a RT primer5′-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATAC-3′
hsa-miR-19a RT primer5′-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACTCAGTTTT-3′
hsa-miR-148b RT primer5′-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACACAAAGTT-3′
hsa-miR-34b RT primer5′-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACCAATCA-3′
hsa-miR-146a RT primer5′-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACAACCCA-3′
hsa-miR-30b-5p RT primer5′-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACAGCTGA-3′
Table
Table 4. Primer for real-time qPCR.
Table 4. Primer for real-time qPCR.
Primer NamePrimer Sequence
hsa-miR-10a-5p Forward primer5′-ACGGGTACCCTGTAGATCCG-3′
hsa-miR-28-5P Forward primer5′-GCCAAAGGAGCTCACAGTCT-3′
hsa-miR-22-5p Forward primer5′-AGGCAGTTCTTCAGTGGCAA-3′
hsa-miR-140-5p Forward primer5′-ACGGGCAGTGGTTTTACCCTA-3′
hsa-miR-18a-5p Forward primer5′-AGGGCTAAGGTGCATCTAGTGC-3′
hsa-miR-128 Forward primer5′-ATCCTTCACAGTGAACCGGT-3′
hsa-miR-124 Forward primer5′-GTGAATTAAGGCACGCGGTG-3′
hsa-miR-19a Forward primer5′-ACGCCTGTGCAAATCTATGC-3′
hsa-miR-148b Forward primer5′-CGGCTCAGTGCATCACAG-3′
hsa-miR-34b Forward primer5′-ACGGGTAGGCAGTGTCATTAGC-3′
hsa-miR-146a Forward primer5′-AGCCGTGAGAACTGAATTCCA-3′
hsa-miR-30b-5p Forward primer5′-ACGGGCTGTAAACATCCTACAC-3′
has-miR Reverse primer5′-CAGTGCAGGGTCCGAGGTAT-4′
caspase 3 Forward primer5′-TGTGAGGCGGTTGTGGAAGAGT-3′
caspase 3 Reverse primer5′-AATGGGGGAAGAGGCAGGTGCA-3′
U6 Forward primer5′-CTCGCTTCGGCAGCACA-3′
U6 Reverse primer5′-AACGCTTCACGAATTTGCGT-3′

4.4. Western Blot

Each group cells were lyzed with Radio Immunoprecipitation Assay (RIPA) cell lysis reagent (Beyotime, Shanghai, China) and the cell protein was collected in 1.5 mL eppendorf. The protein concentration was detected by Bradford Reagent (Amresco, Solon, OH, USA). After the preparation of the SDS-PAGE separating gel and stacking gel, the target protein samples were added 40 µg to per well, transferred to a polyvinylidene fluoride (PVDF) membrane under conditions 200 mA for 1 h and blocked in 5% skimmed milk. Then, the PVDF membrane was incubated overnight at 4 °C with anti-β-actin (Sigma, Saint Louis, MO, USA), anti-caspase-3 antibody (Cell Signaling Technology, Shanghai, China) diluted by Tris-Buffered Saline and Tween (TBST). After washing membrane, incubating with secondary antibody (Cell Signaling Technology, Shanghai, China), washing membrane again, the sample protein quantification was analyzed in odyssey equipment. The β actin was used as reference genes.

4.5. Overexpression of miR-30b

MiR-30b microRNA mimics (GenePharma, Shanghai, China) were utilized to overexpress the miR-30b. In order to analysis of miR-30b suppressing apoptosis, 100 ng miR-30b mimics or miR-30b negative control was transfected into HCAECs with FuGENE HD transfection reagent (Roche, Basel, Switzerland) for 24 h. The success and efficiency of transfection was confirmed by real-time qPCR. After the transfection, the cells were treated with 1 mmol/L Hcy for another 24 h, then the expression of caspase-3 and apoptosis rate were analyzed.

4.6. Statistical Methods

Data were expressed as mean ± standard deviation, t-test was used to compare the experimental group and the control group, one-way ANOVA was used to compare the control group, miR-30b negative group/Hcy + miR-30b negative group, miR-30b mimic group/Hcy + miR-30b mimic group. p < 0.05 was considered significant differences.

5. Conclusions

We found that Hcy can induce apoptosis in HCAECs in a dose-dependent manner. In this process, the expression of caspase-3 was upregulated and miR-30b was downregulated. In addition, overexpression of miR-30b inhibited apoptosis Hcy-induced in HCAECs by downregulating the caspase-3 expression. Therefore, miR-30b may play an important role in apoptosis induced by Hcy in endothelial cells.

Supplementary Materials

Supplementary materials can be found at https://www.mdpi.com/1422-0067/16/08/17682/s1.

Acknowledgments

This work was supported by Department of Cardiology, Changhai Hospital, Second Military Medical University. We thank Jing Qing and his laboratory for assistance with technology and equipment.

Author Contributions

Feng Li, Xiaowei Song, Qi Chen and Jianliang Zhang conceived and designed the experiments; Feng Li and Lei Zhou performed the experiments; Feng Li and Qi Chen analyzed the data and wrote the paper.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Schaffer, A.; Verdoia, M.; Cassetti, E.; Marino, P.; Suryapranata, H.; de Luca, G. Relationship between homocysteine and coronary artery disease. Results from a large prospective cohort study. Thromb. Res. 2014, 134, 288–293. [Google Scholar] [CrossRef] [PubMed]
  2. Sun, Q.; Jia, X.; Gao, J.; Mou, W.; Tong, H.; Wen, X.; Tian, Y. Association of serum homocysteine levels with the severity and calcification of coronary atherosclerotic plaques detected by coronary CT angiography. Int. Angiol. 2014, 33, 316–323. [Google Scholar] [PubMed]
  3. Ma, Y.; Li, L.; Geng, X.B.; Hong, Y.; Shang, X.M.; Tan, Z.; Song, Y.X.; Zhao, G.Y.; Zhao, B.Q.; Tian, M.R. Correlation between hyperhomocysteinemia and outcomes of patients With acute myocardial infarction. Am. J. Ther. 2014. [Google Scholar] [CrossRef] [PubMed]
  4. He, Y.; Li, Y.; Chen, Y.; Feng, L.; Nie, Z. Homocysteine level and risk of different stroke types: A meta-analysis of prospective observational studies. Nutr. Metab. Cardiovasc. Dis. 2014, 24, 1158–1165. [Google Scholar] [CrossRef] [PubMed]
  5. Pate, M.; Damarla, V.; Chi, D.S.; Negi, S.; Krishnaswamy, G. Endothelial cell biology: Role in the inflammatory response. Adv. Clin. Chem. 2010, 52, 109–130. [Google Scholar] [PubMed]
  6. Sipkens, J.A.; Hahn, N.; van den Brand, C.S.; Meischl, C.; Cillessen, S.A.; Smith, D.E.; Juffermans, L.J.; Musters, R.J.; Roos, D.; Jakobs, C.; et al. Homocysteine-induced apoptosis in endothelial cells coincides with nuclear NOX2 and peri-nuclear NOX4 activity. Cell. Biochem. Biophys. 2013, 67, 341–352. [Google Scholar] [CrossRef] [PubMed]
  7. Liu, T.; Hou, D.D.; Zhao, Q.; Liu, W.; Zhen, P.P.; Xu, J.P.; Wang, K.; Huang, H.X.; Li, X.; Zhang, H.; et al. Phytoestrogen ɑ-Zearalanol attenuates homocysteine-induced apoptosis in human umbilical vein endothelial cells. Biomed. Res. Int. 2013, 2013, 813450. [Google Scholar] [CrossRef] [PubMed]
  8. Jia, S.J.; Lai, Y.Q.; Zhao, M.; Gong, T.; Zhang, B.K. Homocysteine-induced hypermethylation of DDAH2 promoter contributes to apoptosis of endothelial cells. Pharmazie 2013, 68, 282–286. [Google Scholar] [PubMed]
  9. Saki, N.; Abroun, S.; Soleimani, M.; Hajizamani, S.; Shahjahani, M.; Kast, R.E.; Mortazavi, Y. Involvement of MicroRNA in T-Cell Differentiation and Malignancy. Int. J. Hematol. Oncol. Stem Cell Res. 2015, 9, 33–49. [Google Scholar] [PubMed]
  10. Asada, S.; Takahashi, T.; Isodono, K.; Adachi, A.; Imoto, H.; Ogata, T.; Ueyama, T.; Matsubara, H.; Oh, H. Downregulation of Dicer expression by serum withdrawal sensitizes human endothelial cells to apoptosis. Am. J. Physiol. Heart Circ. Physiol. 2008, 295, H2512–H2521. [Google Scholar] [CrossRef] [PubMed]
  11. Liu, Y.; Pan, Q.; Zhao, Y.; He, C.; Bi, K.; Chen, Y.; Zhao, B.; Chen, Y.; Ma, X. MicroRNA-155 regulates ROS production, no generation, apoptosis and multiple functions of human brain microvessel endothelial cells under physiological and pathological conditions. J. Cell. Biochem. 2015. [Google Scholar] [CrossRef] [PubMed]
  12. Qin, B.; Cao, Y.; Yang, H.; Xiao, B.; Lu, Z. MicroRNA-221/222 regulate ox-LDL-induced endothelial apoptosis via Ets-1/p21 inhibition. Mol. Cell. Biochem. 2015, 405, 115–124. [Google Scholar] [CrossRef] [PubMed]
  13. Jiang, W.L.; Zhang, Y.F.; Xia, Q.Q.; Zhu, J.; Yu, X.; Fan, T.; Wang, F. MicroRNA-19a regulates lipopolysaccharide-induced endothelial cell apoptosis through modulation of apoptosis signal-regulating kinase 1 expression. BMC Mol. Biol. 2015, 16, 11. [Google Scholar] [CrossRef] [PubMed]
  14. Zhang, Y.; Qin, W.; Zhang, L.; Wu, X.; Du, N.; Hu, Y.; Li, X.; Shen, N.; Xiao, D.; Zhang, H.; et al. MicroRNA-26a prevents endothelial cell apoptosis by directly targeting TRPC6 in the setting of atherosclerosis. Sci. Rep. 2015, 5, 9401. [Google Scholar] [CrossRef] [PubMed]
  15. Liu, D.; Zhang, X.L.; Yan, C.H.; Li, Y.; Tian, X.X.; Zhu, N.; Rong, J.J.; Peng, C.F.; Han, Y.L. MicroRNA-495 regulates the proliferation and apoptosis of human umbilical vein endothelial cells by targeting chemokine CCL2. Thromb. Res. 2015, 135, 146–154. [Google Scholar] [CrossRef] [PubMed]
  16. Fan, J.; Zhang, W.; Liu, Q. Human cytomegalovirus-encoded miR-US25–1 aggravates the oxidised low density lipoprotein-induced apoptosis of endothelial cells. Biomed. Res. Int. 2014, 2014, 531979. [Google Scholar] [CrossRef] [PubMed]
  17. Pan, Y.; Liang, H.; Liu, H.; Li, D.; Chen, X.; Li, L.; Zhang, C.Y.; Zen, K. Platelet-secreted microRNA-223 promotes endothelial cell apoptosis induced by advanced glycation end products via targeting the insulin-like growth factor 1 receptor. J. Immunol. 2014, 192, 437–446. [Google Scholar] [CrossRef] [PubMed]
  18. Zhang, Y.; Chen, N.; Zhang, J.; Tong, Y. Hsa-let-7g miRNA targets caspase-3 and inhibits the apoptosis induced by ox-LDL in endothelial cells. Int. J. Mol. Sci. 2013, 14, 22708–22720. [Google Scholar] [CrossRef] [PubMed]
  19. Sui, X.Q.; Xu, Z.M.; Xie, M.B.; Pei, D.A. Resveratrol inhibits hydrogen peroxide-induced apoptosis in endothelial cells via the activation of PI3K/Akt by miR-126. J. Atheroscler. Thromb. 2014, 21, 108–118. [Google Scholar] [CrossRef] [PubMed]
  20. Zeng, J.; Xiong, Y.; Li, G.; Liu, M.; He, T.; Tang, Y.; Chen, Y.; Cai, L.; Jiang, R.; Tao, J. MiR-21 is overexpressed in response to high glucose and protects endothelial cells from apoptosis. Exp. Clin. Endocrinol. Diabetes 2013, 121, 425–430. [Google Scholar] [CrossRef] [PubMed]
  21. Qin, B.; Xiao, B.; Jiang, T.; Yang, H. Effects of miR-590–5p on ox-LDL-induced endothelial cells apoptosis and LOX-1 expression. J. Cent. South Univ. Med. Sci. 2012, 37, 675–681. [Google Scholar]
  22. Shin, S.; Moon, K.C.; Park, K.U.; Ha, E. MicroRNA-513a-5p mediates TNF-α and LPS induced apoptosis via downregulation of X-linked inhibitor of apoptotic protein in endothelial cells. Biochimie 2012, 94, 1431–1436. [Google Scholar] [CrossRef] [PubMed]
  23. Ruan, W.; Xu, J.M.; Li, S.B.; Yuan, L.Q.; Dai, R.P. Effects of down-regulation of microRNA-23a on TNF-α-induced endothelial cell apoptosis through caspase-dependent pathways. Cardiovasc. Res. 2012, 93, 623–632. [Google Scholar] [CrossRef] [PubMed]
  24. Qin, B.; Xiao, B.; Liang, D.; Xia, J.; Li, Y.; Yang, H. MicroRNAs expression in ox-LDL treated HUVECs: MiR-365 modulates apoptosis and Bcl-2 expression. Biochem. Biophys. Res. Commun. 2011, 410, 127–133. [Google Scholar] [CrossRef] [PubMed]
  25. Mishra, P.K.; Tyagi, N.; Kundu, S.; Tyagi, S.C. MicroRNAs are involved in homocysteine-induced cardiac remodeling. Cell Biochem. Biophys. 2009, 55, 153–162. [Google Scholar] [CrossRef] [PubMed]
  26. Kalani, A.; Kamat, P.K.; Tyagi, S.C.; Tyagi, N. Synergy of homocysteine, microRNA, and epigenetics: A novel therapeutic approach for stroke. Mol. Neurobiol. 2013, 48, 157–168. [Google Scholar] [CrossRef] [PubMed]
  27. McCully, K.S. Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis. Am. J. Pathol. 1969, 56, 111–128. [Google Scholar] [PubMed]
  28. Kerkeni, M.; Tnani, M.; Chuniaud, L.; Miled, A.; Maaroufi, K.; Trivin, F. Comparative study on in vitro effects of homocysteine thiolactone and homocysteine on HUVEC cells: Evidence for a stronger proapoptotic and proinflammative homocysteine thiolactone. Mol. Cell. Biochem. 2006, 291, 119–126. [Google Scholar] [CrossRef] [PubMed]
  29. Li, T.; Sun, Z.L.; Xie, Q.Y. Protective effect of microRNA-30b on hypoxia/reoxygenation-induced apoptosis in H9C2 cardiomyocytes. Gene 2015, 561, 268–275. [Google Scholar] [CrossRef] [PubMed]
  30. Song, C.L.; Liu, B.; Wang, J.P.; Zhang, B.L.; Zhang, J.C.; Zhao, L.Y.; Shi, Y.F.; Li, Y.X.; Wang, G.; Diao, H.Y.; et al. Anti-apoptotic Effect of MicroRNA-30b in Early Phase of Rat Myocardial Ischemia-Reperfusion Injury Model. J. Cell. Biochem. 2015. [Google Scholar] [CrossRef] [PubMed]
  31. Zhu, E.D.; Li, N.; Li, B.S.; Li, W.; Zhang, W.J.; Mao, X.H.; Guo, G.; Zou, Q.M.; Xiao, B. miR-30b, down-regulated in gastric cancer, promotes apoptosis and suppresses tumor growth by targeting plasminogen activator inhibitor-1. PLoS ONE 2014, 9, e106049. [Google Scholar] [CrossRef] [PubMed]
  32. Liao, W.T.; Ye, Y.P.; Zhang, N.J.; Li, T.T.; Wang, S.Y.; Cui, Y.M.; Qi, L.; Wu, P.; Jiao, H.L.; Xie, Y.J.; et al. MicroRNA-30b functions as a tumour suppressor in human colorectal cancer by targeting KRAS, PIK3CD and BCL2. J. Pathol. 2014, 232, 415–427. [Google Scholar] [CrossRef] [PubMed]
  33. Fujiya, M.; Konishi, H.; Mohamed Kamel, M.K.; Ueno, N.; Inaba, Y.; Moriichi, K.; Tanabe, H.; Ikuta, K.; Ohtake, T.; Kohgo, Y.; et al. MicroRNA-18a induces apoptosis in colon cancer cells via the autophagolysosomal degradation of oncogenic heterogeneous nuclear ribonucleoprotein A1. Oncogene 2014, 33, 4847–4856. [Google Scholar] [CrossRef] [PubMed]
  34. Hsu, T.I.; Hsu, C.H.; Lee, K.H.; Lin, J.T.; Chen, C.S.; Chang, K.C.; Su, C.Y.J.; Hsiao, M.; Lu, P.J. MicroRNA-18a is elevated in prostate cancer and promotes tumorigenesis through suppressing STK4 in vitro and in vivo. Oncogenesis 2014, 3, e99. [Google Scholar] [CrossRef] [PubMed]
  35. Song, Y.; Wang, P.; Zhao, W.; Liu, X.; Ma, J.; Xue, Y.; Liu, Y. MiR-18a regulates the proliferation, migration and invasion of human glioblastoma cell by targeting neogenin. Exp. Cell Res. 2014, 324, 54–64. [Google Scholar] [CrossRef] [PubMed]
  36. Mercié, P.; Garnier, O.; Lascoste, L.; Renard, M.; Closse, C.; Durrieu, F.; Marit, G.; Boisseau, R.M.; Belloc, F. Homocysteine-thiolactone induces caspase-independent vascular endothelial cell death with apoptotic features. Apoptosis 2000, 5, 403–411. [Google Scholar] [CrossRef] [PubMed]
  37. Gurda, D.; Handschuh, L.; Kotkowiak, W.; Jakubowski, H. Homocysteine thiolactone and N-homocysteinylated protein induce pro-atherogenic changes in gene expression in human vascular endothelial cells. Amino Acids 2015, 47, 1319–1339. [Google Scholar] [CrossRef] [PubMed]

Share and Cite

MDPI and ACS Style

Li, F.; Chen, Q.; Song, X.; Zhou, L.; Zhang, J. MiR-30b Is Involved in the Homocysteine-Induced Apoptosis in Human Coronary Artery Endothelial Cells by Regulating the Expression of Caspase 3. Int. J. Mol. Sci. 2015, 16, 17682-17695. https://doi.org/10.3390/ijms160817682

AMA Style

Li F, Chen Q, Song X, Zhou L, Zhang J. MiR-30b Is Involved in the Homocysteine-Induced Apoptosis in Human Coronary Artery Endothelial Cells by Regulating the Expression of Caspase 3. International Journal of Molecular Sciences. 2015; 16(8):17682-17695. https://doi.org/10.3390/ijms160817682

Chicago/Turabian Style

Li, Feng, Qi Chen, Xiaowei Song, Lei Zhou, and Jianliang Zhang. 2015. "MiR-30b Is Involved in the Homocysteine-Induced Apoptosis in Human Coronary Artery Endothelial Cells by Regulating the Expression of Caspase 3" International Journal of Molecular Sciences 16, no. 8: 17682-17695. https://doi.org/10.3390/ijms160817682

APA Style

Li, F., Chen, Q., Song, X., Zhou, L., & Zhang, J. (2015). MiR-30b Is Involved in the Homocysteine-Induced Apoptosis in Human Coronary Artery Endothelial Cells by Regulating the Expression of Caspase 3. International Journal of Molecular Sciences, 16(8), 17682-17695. https://doi.org/10.3390/ijms160817682

Article Metrics

Back to TopTop